Drug firm Torrent Pharmaceuticals today reported a consolidated net profit of Rs 229 crore for the third quarter ended December 31, 2016.
The company had posted a net profit of Rs 290 crore for the corresponding period of the previous fiscal, Torrent Pharmaceuticals said in a filing to BSE.
Consolidated total income from operations stood at Rs 1,443 crore for the quarter under consideration, compared to Rs 1,542 crore for the same period year ago.
"Previous period include exceptional revenues and profits which was primarily on account of the launch of a new product in the US market, which had limited competition," Torrent Pharmaceuticals said.
In another filing to the bourses, the company declared an interim dividend of Rs 10 (200 per cent) per equity share of Rs 5.
Shares of Torrent Pharmaceuticals today closed at Rs 1,315.20 per scrip on BSE, up 2.04 per cent from its previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
